Citations 762

P3‐006: Neurons during early development are highly vulnerable to TDP‐43 dysregulation

Alzheimer's & Dementia | August 1, 2011 | Volume: 7 | Issue: 4S_Part_15 | Pages: No page available

10.1016/j.jalz.2011.05.1445

P1‐229: Genome‐Wide Association Study of Brain Gene Expression Levels (eGWAS)

Alzheimer's & Dementia | August 1, 2011 | Volume: 7 | Issue: 4S_Part_5 | Pages: No page available

10.1016/j.jalz.2011.05.509

P2‐103: Antemortem increase in gray matter diffusivity is associated with decreased neuronal density

Alzheimer's & Dementia | August 1, 2011 | Volume: 7 | Issue: 4S_Part_10 | Pages: No page available

10.1016/j.jalz.2011.05.992

O2‐07‐03: Alzheimer's disease from a pathological point of view and what neurologists can learn from it

Alzheimer's & Dementia | August 1, 2011 | Volume: 7 | Issue: 4S_Part_9 | Pages: No page available

10.1016/j.jalz.2011.05.883

P2‐326: Towards a comprehensive analysis of the role of inflammatory mediators on Alzheimer's like pathology in pre‐clinical mouse models

Alzheimer's & Dementia | August 1, 2011 | Volume: 7 | Issue: 4S_Part_12 | Pages: No page available

10.1016/j.jalz.2011.05.1202

P1‐217: Replication of LOAD GWAS Associations

Alzheimer's & Dementia | August 1, 2011 | Volume: 7 | Issue: 4S_Part_5 | Pages: No page available

10.1016/j.jalz.2011.05.496

P3‐003: Effect of strain background on pathology progression in tau mouse model

Alzheimer's & Dementia | August 1, 2011 | Volume: 7 | Issue: 4S_Part_15 | Pages: No page available

10.1016/j.jalz.2011.05.1442

IC‐P‐130: Antemortem increase in gray matter diffusivity is associated with decreased neuronal density

Alzheimer's & Dementia | August 1, 2011 | Volume: 7 | Issue: 4S_Part_2 | Pages: No page available

10.1016/j.jalz.2011.05.094

Nuclear translocation of AMPK-α1 potentiates striatal neurodegeneration in Huntington’s disease

Journal of Cell Biology | July 18, 2011 | Volume: 194 | Issue: 2 | Pages: 209-227

10.1083/jcb.201105010 | PMID 21768291

Adenosine monophosphate–activated protein kinase (AMPK) is a major energy sensor that maintains cellular energy homeostasis. Huntington’s disease (HD) is a neurodegenerative disorder caused by the expansion of CAG repeats in the huntingtin (Htt) gene. In this paper, we report that activation of the α1 isoform of AMPK (AMPK-α1) occurred in striatal neurons of humans and mice with HD. Overactivation of AMPK in the striatum caused brain atrophy, facilitated neuronal loss, and increased formation of Htt aggregates in a transgenic mouse model (R6/2) of HD. Such nuclear accumulation of AMPK-α1 was activity dependent. Prevention of nuclear translocation or inactivation of AMPK-α1 ameliorated cell death and down-regulation of Bcl2 caused by mutant Htt (mHtt). Conversely, enhanced expression of Bcl2 protected striatal cells from the toxicity evoked by mHtt and AMPK overactivation. These data demonstrate that aberrant activation of AMPK-α1 in the nuclei of striatal cells represents a new toxic pathway induced by mHtt.
A family with parkinsonism, essential tremor, restless legs syndrome, and depression

Neurology | May 9, 2011 | Volume: 76 | Issue: 19 | Pages: 1623-1630

10.1212/wnl.0b013e318219fb42 | PMID 21555728